TABLE 4.
Analyses of clinical and peripheral blood parameters of Patients with IBD-associated Neoplasia vs. patients without neoplasia.
| Variables | IBD-associated Neoplasia (N = 12) |
IBD without neoplasia (N = 350) |
P- value |
| Gender | 0.370 | ||
| Male | 7(58.3) | 234(66.9) | |
| Female | 5(41.7) | 116(33.1) | |
| Age(years) | 0.410 | ||
| ≤50 | 5(41.7) | 121(34.6) | |
| >50 | 7(58.3) | 229(65.4) | |
| Time from diagnosis(month) | 0.033 | ||
| ≤120 | 8(66.7) | 314(89.7) | |
| >120 | 4(33.3) | 36(10.3) | |
| Extent of IBD | <0.001 | ||
| Rectal | 1(8.3) | 23(6.6) | |
| rectosigmoid | 1(8.3) | 45(12.9) | |
| Left colon | 2(16.6) | 83(23.7) | |
| Extensive colon | 0(0) | 139(39.7) | |
| total colon | 8(66.7) | 60(17.1) | |
| Intestinal resection in anamnesis | 0.010 | ||
| Yes | 3(25) | 12(3.4) | |
| No | 9(75) | 338(96.6) | |
| infection Clostridium difficile | 0.171 | ||
| Yes | 4(33.3) | 64(18.3) | |
| No | 8(66.7) | 286(81.7) | |
| Abscess or fistula | 0.099 | ||
| Yes | 3(25) | 32(9.4) | |
| No | 9(75) | 318(90.6) | |
| History of smoking | 0.453 | ||
| Yes | 2(16.7) | 43(12.3) | |
| No | 10(83.3) | 307(87.7) | |
| HBsAg | 0.567 | ||
| Positive | 1(8.3) | 23(6.6) | |
| Negative | 11(91.7) | 327(93.4) | |
| Colonic polyp formation | 0.012 | ||
| Yes | 4(33.3) | 26(7.4) | |
| No | 8(66.7) | 324(92.6) | |
| NAR*100 | 0.186 | ||
| ≤16.6 | 6(50.0) | 241(68.9) | |
| >16.6 | 6(50.0) | 109(31.1) | |
| NPAR*1,000 | 0.002 | ||
| ≤62.1 | 4(33.3) | 269(76.9) | |
| >62.1 | 8(66.7) | 81(23.1) | |
| AAPR | 0.685 | ||
| ≤0.38 | 2(16.7) | 50(14.3) | |
| >0.38 | 10(83.3) | 300(85.7) | |
| AGR | 0.551 | ||
| ≤2.05 | 5(41.7) | 118(33.7) | |
| >2.05 | 7(58.3) | 232(66.3) | |
| AFR | 1.000 | ||
| ≤0.18 | 4(33.3) | 119(34.0) | |
| >0.18 | 8(66.7) | 231(66.0) | |
| FPR*100 | |||
| ≤124.31 | 6(50.0) | 176(50.3) | 0.984 |
| >124.31 | 6(50.0) | 174(49.7) | |
| PNI | |||
| ≤42.15 | 8(66.7) | 87(24.9) | 0.003 |
| >42.15 | 4(33.3) | 263(75.1) |
Bold fonts represented that P value was < 0.05.